[
    [
        {
            "time": "",
            "original_text": "智飞生物拟开发新型冠状病毒疫苗，蓝黛传动取消2月5日股东大会",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新型冠状病毒疫苗",
                    "开发",
                    "蓝黛传动",
                    "取消股东大会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物拟开发新型冠状病毒疫苗，蓝黛传动取消2月5日股东大会",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物联手中科院微生物所抗疫情 加快新型冠状病毒疫苗开发",
            "features": {
                "keywords": [
                    "智飞生物",
                    "中科院微生物所",
                    "新型冠状病毒疫苗",
                    "开发",
                    "抗疫"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物联手中科院微生物所抗疫情 加快新型冠状病毒疫苗开发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物签订合作开发新型冠状病毒疫苗框架协议",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新型冠状病毒疫苗",
                    "框架协议",
                    "合作开发"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物签订合作开发新型冠状病毒疫苗框架协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-02-02",
            "original_text": "2月2日晚间上市公司十大重磅公告",
            "features": {
                "keywords": [
                    "上市公司",
                    "重磅公告",
                    "2月2日"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2月2日晚间上市公司十大重磅公告",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物(300122.SZ)：与中国科学院微生物研究所合作开发新型冠状病毒疫苗",
            "features": {
                "keywords": [
                    "智飞生物",
                    "中国科学院微生物研究所",
                    "新型冠状病毒疫苗",
                    "合作开发"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)：与中国科学院微生物研究所合作开发新型冠状病毒疫苗",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]